You are here » Home » Companies » Company Overview » Auromed Ltd

Auromed Ltd.

BSE: 532103 Sector: Health care
NSE: N.A. ISIN Code: N.A.
BSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN
PREVIOUS CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty

Auromed Ltd. (AUROMED) - Company History

Promoted by D Srinivasvaradhan, Auromed was incorporated in Mar.95 as a public limited company. The company is in the process of establishing a multipurpose bulk drug and pharmaceutical manufacturing plant at Guduvancheri, Tamilnadu. It came out with a public issue in Jun.'96 to part-finance this project. The company proposes to manufacture bronopol BP, norfloxacin BP and diclofenac sodium BP, betaine base and betaine hydrochloride BP. Bronopol will be exported to European countries for which the company has firm marketing tie-up with Transtech International, UK; Herman Gshutte & Co, Germany and Pharmaco, Germany. Betaine base and betaine hydrochloride will also be exported through marketing agreement with Perry Pharmaceuticals, UK; Lab-Tech Pharma, Switzerland and Webster Pharma Technique, France . Norfloxacin and diclofenac sodium will be marketed in the domestic market.